ArticleJournal of cancer & metastasis research2022

Nanotechnology in the development of small and large molecule tyrosine kinase inhibitors and immunotherapy for the treatment of HER2-positive breast cancer.

Victor Ejigah et al.PubMed ↗Full text ↗

No numbers read from the abstract.